Hematology TimesHealth Canada approves new use for brentuximab vedotinJuly 26, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Hematology NewsAvelumab induces response in Hodgkin lymphoma after failed allo-SCTJuly 20, 2017Hodgkin LymphomaLymphoma & Plasma Cell DisordersImmuno-oncology
Hematology TimesNivolumab for long-term treatment of cHL after auto-HSCTJuly 7, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Hematology TimesSingle-dose NEPA found non-inferior to aprepitant/granisetronJune 29, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated IssuesHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesLess is more in PET-negative, advanced HLJune 28, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Hematology TimesBrentuximab meets phase 3 primary endpoint in frontline advanced HLJune 27, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Oncology PracticeCARs race for supremacy against aggressive non-Hodgkin lymphomaJune 25, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaFollicular Lymphoma
Oncology PracticeOverall survival better in advanced Hodgkin lymphoma with shorter eBEACOPPJune 24, 2017Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology TimesNew frontline treatments needed for Hodgkin lymphomaJune 22, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Hematology TimesSevere health conditions decrease among childhood cancer survivorsJune 4, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Oncology PracticeSevere health conditions decline in childhood cancer survivorsJune 3, 2017Patient & Survivor CarePediatricsHodgkin LymphomaAggressive Lymphomas
Hematology TimesGlobal study reveals healthcare inequity, preventable deathsMay 23, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesHodgkin Lymphoma
Hematology TimesHL survivors should be screened for CAD after chest irradiationMay 11, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Hematology TimesNovel inhibitor proves ‘potent’ in hematologic malignanciesMay 9, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLMyelodysplastic SyndromeHodgkin Lymphoma
Hematology TimesEC approves pembrolizumab for cHL patientsMay 8, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
